CureVac COVID vaccine let-down spotlights mRNA design challenges

Elie Dolgin • June 18, 2021

Scientists are searching for explanations to disappointing final-stage trial results. These insights could help guide the future development of mRNA vaccines.

Two vaccines made using messenger RNA (mRNA) have proved spectacularly successful at warding off COVID-19, but a third mRNA-based candidate has flopped in a final-stage trial, according to an initial report released this week.


Researchers are now asking why — and some think that choices about the type of mRNA chemistry used might be to blame. Any insight could help to guide the future design of mRNA vaccines against COVID-19 or other diseases.


Continue reading at Nature.

Damaged 15th century painting by the Master of the Prado Adoration of the Magi
By Elie Dolgin June 12, 2025
Pixels meet paint, as a digital “mask” conceals damage on a 15th-century painting.
Cartoon of man in swimming trunks and goggles standing on an auto-injector for medicine
By Elie Dolgin June 11, 2025
Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.